Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This survey is conducted for preparing application materials for re-examination under the
Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the
clinical usefulness of sitagliptin/metformin (JANUMET) through collecting the safety and
efficacy information according to the Re-examination Regulation for New Drugs.